Scientists uncover new disease-driving mechanism to treat atheroschlerosis
Atherosclerotic plaques in the arteries affect 42% of adults living without heart disease
Read More
Tag: Bristol Medical School
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
